| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Cell Biology, Institute of Ophthalmology, and
Neuroinflammation Group, Department of Neurochemistry, Institute of Neurology, University College London, London, United Kingdom;
Drug Discovery Program, Departments of Oncology and Biochemistry and Molecular Biology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612; and
Department of Chemistry, Yale University, New Haven, CT 06520
The ICAM-1-mediated brain endothelial cell (EC)-signaling pathway induced by adherent lymphocytes is a central element in facilitating lymphocyte migration through the tight endothelial barrier of the brain. Rho proteins, which must undergo posttranslational prenylation to be functionally active, have been shown to be an essential component of this signaling cascade. In this study, we have evaluated the effect of inhibiting protein prenylation in brain ECs on their ability to support T lymphocyte migration. ECs treated in vitro with protein prenylation inhibitors resulted in a significant reduction in transendothelial T lymphocyte migration. To determine the therapeutic potential of this approach, an animal model of multiple sclerosis, experimental autoimmune encephalomyelitis, was induced in Biozzi ABH mice. Animals treated before disease onset with protein prenylation inhibitors exhibited a dramatic and significant reduction in both leukocyte infiltration into the CNS and clinical presentation of disease compared with untreated animals. These studies demonstrate, for the first time, the potential for pharmacologically targeting CNS EC signaling responses, and particularly endothelial Rho proteins, as a means of attenuating leukocyte recruitment to the CNS.
This article has been cited by other articles:
|
|
 |
|
  A. Reijerkerk, G. Kooij, S. M. A. van der Pol, T. Leyen, B. van het Hof, P.-O. Couraud, D. Vivien, C. D. Dijkstra, and H. E. de Vries Tissue-Type Plasminogen Activator Is a Regulator of Monocyte Diapedesis through the Brain Endothelial Barrier J. Immunol., September 1, 2008; 181(5): 3567 - 3574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Paintlia, M. K. Paintlia, A. K. Singh, and I. Singh Inhibition of Rho Family Functions by Lovastatin Promotes Myelin Repair in Ameliorating Experimental Autoimmune Encephalomyelitis Mol. Pharmacol., May 1, 2008; 73(5): 1381 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Waiczies, I. Bendix, T. Prozorovski, M. Ratner, I. Nazarenko, C. F. Pfueller, A. U. Brandt, J. Herz, S. Brocke, O. Ullrich, et al. Geranylgeranylation but Not GTP Loading Determines Rho Migratory Function in T Cells J. Immunol., November 1, 2007; 179(9): 6024 - 6032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Schreibelt, G. Kooij, A. Reijerkerk, R. van Doorn, S. I. Gringhuis, S. van der Pol, B. B. Weksler, I. A. Romero, P.-O. Couraud, J. Piontek, et al. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling FASEB J, November 1, 2007; 21(13): 3666 - 3676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schreibelt, R. J. P. Musters, A. Reijerkerk, L. R. de Groot, S. M. A. van der Pol, E. M. L. Hendrikx, E. D. Dopp, C. D. Dijkstra, B. Drukarch, and H. E. de Vries Lipoic Acid Affects Cellular Migration into the Central Nervous System and Stabilizes Blood-Brain Barrier Integrity J. Immunol., August 15, 2006; 177(4): 2630 - 2637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. K. Peterson, P. Kelly, C. A. Weinbaum, and P. J. Casey A Novel Protein Geranylgeranyltransferase-I Inhibitor with High Potency, Selectivity, and Cellular Activity J. Biol. Chem., May 5, 2006; 281(18): 12445 - 12450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Frohman, M. Filippi, O. Stuve, S. G. Waxman, J. Corboy, J. T. Phillips, C. Lucchinetti, J. Wilken, N. Karandikar, B. Hemmer, et al. Characterizing the Mechanisms of Progression in Multiple Sclerosis: Evidence and New Hypotheses for Future Directions Arch Neurol, September 1, 2005; 62(9): 1345 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Gegg, R. Harry, D. Hankey, H. Zambarakji, G. Pryce, D. Baker, P. Adamson, V. Calder, and J. Greenwood Suppression of Autoimmune Retinal Disease by Lovastatin Does Not Require Th2 Cytokine Induction J. Immunol., February 15, 2005; 174(4): 2327 - 2335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J.A. Hendriks, J. Alblas, S. M.A. van der Pol, E. A.F. van Tol, C. D. Dijkstra, and H. E. de Vries Flavonoids Influence Monocytic GTPase Activity and Are Protective in Experimental Allergic Encephalitis J. Exp. Med., December 20, 2004; 200(12): 1667 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Running, M. Lavy, H. Sternberg, A. Galichet, W. Gruissem, S. Hake, N. Ori, and S. Yalovsky Enlarged meristems and delayed growth in plp mutants result from lack of CaaX prenyltransferases PNAS, May 18, 2004; 101(20): 7815 - 7820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Greenwood, C. L. Amos, C. E. Walters, P.-O. Couraud, R. Lyck, B. Engelhardt, and P. Adamson Intracellular Domain of Brain Endothelial Intercellular Adhesion Molecule-1 Is Essential for T Lymphocyte-Mediated Signaling and Migration J. Immunol., August 15, 2003; 171(4): 2099 - 2108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. ADAMSON, B. WILBOURN, S. ETIENNE-MANNEVILLE, V. CALDER, E. BERAUD, G. MILLIGAN, P.-O. COURAUD, and J. GREENWOOD Lymphocyte trafficking through the blood-brain barrier is dependent on endothelial cell heterotrimeric G-protein signaling FASEB J, August 1, 2002; 16(10): 1185 - 1194. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
